Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video)
"Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project…

What happens next will shock you…"
Click here to see what happened.

IBT Insider Trading (International Biotechnology Trust)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £155,070
Insider Selling (Last 12 Months): GBX 0

International Biotechnology Trust Insider Trading History Chart

International Biotechnology Trust Share Price & Price History

GBX 720
▼ -16 (-2.17%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
#1 trading secret
He started as a janitor’s grandson… and ended up becoming a million dollar hedge fund insider... Now he’s revealing the #1 trading secret he learned during his time on Wall Street…
Continue Reading
pixel

International Biotechnology Trust Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/21/2020Jim HorsburghInsiderBuy15,000GBX 849£127,350
9/15/2020Patrick MageeInsiderBuy3,500GBX 792£27,720
2/26/2020Caroline GulliverInsiderBuy2,500GBX 592£14,800
See Full Table
International Biotechnology Trust logo
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.
Read More

Today's Range

Now: GBX 720
711.33
738

50 Day Range

MA: GBX 770
736
812

52 Week Range

Now: GBX 720
618
862

Volume

292,717 shs

Average Volume

97,769 shs

Market Capitalization

£296.31 million

P/E Ratio

N/A

Dividend Yield

3.75%

Beta

N/A

Who are the company insiders with the largest holdings of International Biotechnology Trust?

International Biotechnology Trust's top insider shareholders include:
  1. Caroline Gulliver (Insider)
  2. Jim Horsburgh (Insider)
  3. Patrick Magee (Insider)
#1 trading secret
He started as a janitor’s grandson… and ended up becoming a million dollar hedge fund insider... Now he’s revealing the #1 trading secret he learned during his time on Wall Street…
Continue Reading
pixel